SCHEMBL9717529

SCHEMBL9717529

CCC/C(=C\c1ccc(OC2(C(=O)O)CCC2)c(Cl)c1Cl)[N+](=O)[O-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9717540 1.00 — —
SCHEMBL9717538 1.00 — —
SCHEMBL9717522 0.93 MEN1 (0.30) —
SCHEMBL9717526 0.93 MEN1 (0.30) —
SCHEMBL9717517 0.93 MEN1 (0.30) —
SCHEMBL9717563 0.81 NPSR1 (0.33) —
SCHEMBL9717558 0.81 NPSR1 (0.33) —
SCHEMBL9717501 0.81 MEN1 (0.31) —
SCHEMBL9717507 0.81 MEN1 (0.31) —
SCHEMBL9717553 0.81 MEN1 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0240256-B1 COMPOUNDS USEFUL IN TREATING SICKLE CELL ANEMIA MERCK & CO. INC. (US) 1992-04-29 — — EP disclosed
US-4751244-A NITROALKENYL CARBOXYLIC ACIDS MERCK & CO., INC. (US) 1988-06-14 — — US disclosed
EP-0240256-A2 Compounds useful in treating sickle cell anemia MERCK & CO. INC. (US) 1987-10-07 — — EP disclosed
Send feedback